Lactiga
PrivateLast Round
Grant
Sep 4, 2025
Total Funding Raised
$3.61M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lactiga operates in Healthcare & Life Sciences and is based in New Jersey. Its latest recorded funding round was a Grant round in September 2025.
Lactiga is a biotechnology company developing novel mucosal antibodies derived from human breastmilk to address chronic disease and immune dysregulation in vulnerable populations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lactiga Comparables
Compare Lactiga with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Grifols | 71% | |
| Octapharma AG | 67% | |
| Takeda | 66% |
For institutional investors. Book with your work email.
Lactiga Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 4, 2025 | ||||
| Series A | Sep 4, 2025 | ||||
| Grant | Feb 3, 2025 | ||||
| Grant | Sep 21, 2022 | ||||
| Pre Seed | Sep 21, 2022 | ||||
Seed | Nov 2, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lactiga Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Jersey Commission on Science, Innovation and Technology | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| Innovation Factory | Grant |
| 1517 Fund | Pre Seed |
| NIH RADx | Grant |
| LaunchYU | Accelerator |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 2479% MoM, reaching 1.1K.
- Feb 3, 2025
Received grant from National Institute of Allergy and Infectious Diseases and NIH RADx.
For institutional investors. Book with your work email.
Lactiga Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lactiga's valuation, stock price, and market status.
Is Lactiga a public or private company?
Lactiga is a private company.
What is the current stock price of Lactiga?
Lactiga is a private company, so its shares have no public market price. Caplight tracks Lactiga's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lactiga worth (valuation)?
Valuation information for Lactiga is not publicly available.
Can I buy Lactiga stock?
Lactiga shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lactiga's last funding round?
Lactiga's most recent funding round was Grant on September 4, 2025.
Who are the main investors in Lactiga?
Key investors in Lactiga include 1517 Fund.
Will Lactiga IPO soon?
No public IPO plans have been announced for Lactiga.
How can I track Lactiga secondary market activity?
Caplight tracks bids, offers, and trades in Lactiga's shares on secondary markets.